Position in ARWR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$552,073
-$408,058 QoQ
Shares Held
8,805
-39.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 24%
Shared 76%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VIRTUS ADVISERS, LLC holds $6,375,075 across 18 Biotechnology names. ARWR ranks #6 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
42,974 | $956,600 | |
| 2 | GMAB |
Genmab A/S
|
30,830 | $827,168 | |
| 3 | INVA |
Innoviva, Inc.
|
26,946 | $627,841 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
25,800 | $561,408 | |
| 5 | EXEL |
Exelixis, Inc.
|
13,000 | $557,570 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
8,805 | $552,073 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
15,850 | $439,045 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
15,399 | $431,325 |
All Filings in ARWR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $552,073 | 8,805 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $960,131 | 14,462 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $498,793 | 14,462 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $247,174 | 15,644 | Shares | Other | 2026-02-13 | |
| 2024-12-31 | $60,366 | 3,211 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $67,368 | 3,478 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $88,781 | 3,416 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $86,686 | 3,031 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $99,235 | 3,243 | Shares | Other | 2024-02-15 | |
| 2023-09-30 | $75,209 | 2,799 | Shares | Other | 2023-11-07 | |
| 2023-06-30 | $109,725 | 3,077 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $78,181 | 3,078 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $172,947 | 4,264 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $123,673 | 3,742 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $130,910 | 3,718 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $103,845 | 2,258 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $159,120 | 2,400 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $150,019 | 2,403 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $209,534 | 2,530 | Shares | Other | 2021-08-10 | |
| 2021-03-31 | $265,637 | 4,006 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $302,162 | 3,938 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $405,797 | 9,424 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $462,348 | 10,705 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $155,386 | 5,401 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||